BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 28, 2008
View Archived Issues
EP4 receptor blocker may be useful in treating chronic arthritis
Read More
Mechanisms behind protective effects of KAI-9803 in stroke model determined
Read More
Glatiramer and steroid combination treatment beneficial in relapsing-remitting multiple sclerosis
Read More
GTx reports results from phase III clinical trial of toremifene citrate 80 mg
Read More
Recent Janssen patent discloses antiallergic and antiasthmatic agents
Read More
New local anesthetic compounds patented by PharmacoFore
Read More
Acambis initiates preclinical testing of dl5-29 HSV-2 vaccine
Read More
Bionomics initiates treatment in phase I clinical trial of BNC-105 anticancer drug
Read More
CollaGenex signs definitive merger agreement with Galderma
Read More
Verona Pharma plans clinical trials of RPL-554 for allergic respiratory diseases
Read More
Dr. Falk Pharma initiates phase II clinical study of Dong-A's udenafil for portal hypertension
Read More
ADVR signs research agreement with Northeastern University for AVR-118 in cancer
Read More
SV2A protein a target in partial and generalized epilepsy
Read More
Javelin completes subject accrual in the last of four phase I clinical studies of PMI-150
Read More
Health Canada approves Welichem Biotech's CTA for phase IIa clinical trial of WBI-1001
Read More
Actelion withdraws application to EMEA for extension of indication for Zavesca
Read More
Addex achieves preclinical milestone in agreement with Merck & Co. for allosteric modulators
Read More
ImmuPharma initiates dosing in phase IIb trial of IPP-201101 for systemic lupus erythematosus
Read More
Osiris reports interim results from phase I trial of Prochymal for myocardial infarction
Read More
Synthetic Blood awarded USD 1.9 million grant for phase IIb clinical trial of Oxycyte
Read More
Immunosyn reports results from proof-of-concept trial of SF-1019 for diabetic ulcers
Read More
VioQuest and the National Cancer Institute enter agreement for Akt inhibitor VQD-002
Read More
NPIL commences phase I P-1201-07 trials for metabolic disorders in Europe
Read More
FDA issues not approvable letter to Kyowa Hakko for istradefylline in Parkinson's
Read More
Novel antithrombotic agents described in recent Fournier and sanofi-aventis patents
Read More